Zydus receives final approval for Candesartan Cilexetil Tablets
From USFDA
Zydus Cadila has received the final approval from the USFDA to market Candesartan Cilexetil Tablets USP 4mg, 8mg, 16mg and 32mg. The drug is used to treat high blood pressure (hypertension) in adults and will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content